Telitacicept treatment group:None

2 trials

Sponsors

Zhangzhou Municipal Hospital of Fujian Province, The Third Xiangya Hospital, Central South University

Conditions

IgA NephropathyLupus nephritis

Phase 4

A prospective, single-center, real-world study of telitacicept for the treatment of hematuria in patients with IgA nephropathy

Active, not recruitingChiCTR2600124141

The Third Xiangya Hospital, Central South UniversityIgA Nephropathy

Start: 2026-05-10Updated: 2026-05-11

Unknown Phase

The efficacy and safety of telitacicept in patients with lupus nephritis:a single-center, real-world retrospective study

Active, not recruitingChiCTR2300076828

Zhangzhou Municipal Hospital of Fujian ProvinceLupus nephritis

Start: 2023-07-03Updated: 2023-10-22